Corporate Board Profile
Tech Score: 0/100
| Filing Date | Source Excerpt |
|---|---|
| 2019-03-28 | Our Audit Committee consists of Mr. Consiglio (chair), Ms. Mundkur, and Mr. Nordhoff, each of whom is an independent member of our Board of Directors ... Ms. Mundkur was appointed to the Board of Directors in November 2018. A partial year retainer of $30,000 and a prorata annual equity grant equivalent to $75,000 or 32,608 restricted stock units was awarded to Ms. Mundkur on February 20, 2019. |
| 2020-04-10 | Christine Mundkur has been one of our directors since November 2018. ... Ms. Mundkur most recently served as Chief Executive Officer and non-voting Chairman of the Board of Directors for Impopharma Inc., a developer of complex formulations focused on inhaled pharmaceutical products, from February 2013 to February 2017. ... The Board believes that Ms. Mundkur's business experience, including her experience as chairman of the board and chief executive officer at a pharmaceutical company developing inhaled drugs, combined with her business acumen and judgment provide our Board with valuable operational expertise and leadership and qualifies her to serve on our Board of Directors. |
| 2021-04-07 | Christine Mundkur has been one of our directors since November 2018. ... Our Audit Committee consists of Mr. Consiglio (chair), Ms. Grancio, Mr. Hooper, Ms. Kay and Ms. Mundkur, each of whom is an independent member of our Board of Directors ... (2) Member of the Nominating and Corporate Governance Committee. ... (3) Member of the Audit Committee. ... Director Compensation Table ... Christine Mundkur ... Total 182,818 |
| 2022-03-30 | CHRISTINE MUNDKUR Director Member, Audit Committee Age: 53 Director since: 2018 The Board believes that Ms. Mundkur’s business experience, including her experience as chair of the board and chief executive officer at a pharmaceutical company developing inhaled drugs, combined with her business acumen and judgment provide our Board with valuable operational expertise and leadership and qualify her to serve on our Board of Directors. |
| 2023-04-10 | CHRISTINE MUNDKUR Director Member, Audit Committee and Nominating and Corporate Governance Committee Age: 54 Director since: 2018 |
| 2024-04-05 | CHRISTINE MUNDKUR Director Member, Audit Committee and Nominating and Corporate Governance Committee Age: 55 Director since: 2018 The Board believes that Ms. Mundkur’s business experience, including her experience as chair of the board and chief executive officer at a pharmaceutical company developing inhaled drugs, combined with her business acumen and judgment provide our Board with valuable operational expertise and leadership and qualify her to serve on our Board of Directors. |
| 2025-04-01 | CHRISTINE MUNDKUR Director Member, Audit Committee and Nominating and Corporate Governance Committee Age: 56 Director since: 2018 ... Director Compensation Table ... Christine Mundkur $65,000 fees earned in cash, $155,959 stock awards, total $220,959. |
Data sourced from SEC filings. Last updated: 2026-02-03